This webinar was recorded on the 19th April 2023 and is part of our BSG/BASL AUD webinar series, focused on alcohol use disorder, cancer risk and extra-hepatic ill-health.

Please see below the learning objectives, the programme from the webinar, and the recording.

Key learning objectives

• Provide an understanding of the common physical harms associated with alcohol/AUD, beyond cirrhosis
• Consider the risk of HCC and the role of surveillance and or novel biomarkers/predictive models in the management of ARLD
• Explore the incidence of non-hepatic malignancy in heavy drinkers/AUD
• Understand the extra-hepatic physical harm which arises from alcohol and whether it is possible to survey for any of this

Programme

18:00 Welcome and introduction
Dr Ahmed Elsharkawy, Consultant Hepatologist, Queen Elizabeth Hospital Birmingham

18:05 Keynote talk on Alcohol use disorder – Cancer risk and extra-hepatic ill-health
Dr Ramon Bataller, Chief of Hepatology/Liver Unit, Hospital Clinic in Barcelona

18:45 Q&A Panel discussion
Chairs: Dr Steven Masson, Dr Ashwin Dhanda, Plymouth and Dr Ahmed Elsharkawy, Birmingham
Speaker: Dr Ramon Bataller, Chief of Hepatology/Liver Unit, Hospital Clinic in Barcelona

19:00 Thank you and closing remarks
Dr Ahmed Elsharkawy, Consultant Hepatologist, Queen Elizabeth Hospital Birmingham